CIK 0001478242 · Large accelerated filer
IQVIA HOLDINGS INC.
Sign in to watch- Ticker
- IQV
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271341991
- Phone
- 919-998-2000
- Business address
- 2400 ELLIS ROAD, DURHAM, NC, 27703
- Former names
- Quintiles IMS Holdings, Inc., Quintiles Transnational Holdings Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,936,907
- in 2 filings
Net −$1,936,907. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-20 | STAUB W RICHARD See Remarks | Option exercise | +9,692 | $53.26 | $516K | 29,752 |
| 2019-02-20 | STAUB W RICHARD See Remarks | Option exercise | +3,500 | $64.67 | $226K | 33,252 |
| 2019-02-20 | STAUB W RICHARD See Remarks | Option exercise | +7,425 | $64.93 | $482K | 40,677 |
| 2019-02-20 | STAUB W RICHARD See Remarks | Sale | −10,925 | $140.46 | $1.5M | 29,752 |
| 2019-02-20 | STAUB W RICHARD See Remarks | Sale | −16,100 | $140.60 | $2.3M | 13,652 |
| 2019-02-20 | STAUB W RICHARD See Remarks | Option exercise · Employee Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2019-02-20 | STAUB W RICHARD See Remarks | Option exercise · Employee Stock Option (Right to Buy) | −9,692 | 7,508 | ||
| 2019-02-20 | STAUB W RICHARD See Remarks | Option exercise · Employee Stock Option (Right to Buy) | −3,500 | 3,500 | ||
| 2019-02-20 | STAUB W RICHARD See Remarks | Option exercise · Employee Stock Option (Right to Buy) | −7,425 | 2,475 | ||
| 2019-02-14 | Rittenmeyer Ronald A Director | Option exercise | +7,680 | $26.05 | $200K | 66,987 |
| 2019-02-14 | Rittenmeyer Ronald A Director | Sale | −7,680 | $138.00 | $1.1M | 59,307 |
| 2019-02-14 | Rittenmeyer Ronald A Director | Option exercise · Employee Stock Option (Right to Buy) | −7,680 | 0 | ||
| 2019-02-14 | BOUSBIB ARI See Remarks | Grant or award | +96,000 | $21.36 | $2.1M | 826,137 |
| 2019-02-14 | BOUSBIB ARI See Remarks | Sale | −96,000 | $140.00 | $13.4M | 730,137 |
| 2019-02-14 | BOUSBIB ARI See Remarks | Option exercise · Employee Stock Option (Right to Buy) | −96,000 | 96,000 | ||
| 2019-02-13 | GOGGINS COLLEEN A Director | Grant or award · Deferred Shares | +218 | $131.82 | $29K | 218 |
| 2019-02-13 | BOUSBIB ARI See Remarks | Grant or award · Stock Appreciation Right | +184,364 | 184,364 | ||
| 2019-02-13 | Knightly Kevin C See Remarks | Grant or award · Stock Appreciation Right | +18,436 | 18,436 | ||
| 2019-02-13 | Korakis Emmanuel N Sr. Vice President, Controller | Grant or award · Stock Appreciation Right | +3,687 | 3,687 | ||
| 2019-02-13 | MCDONNELL MICHAEL R EVP and CFO | Grant or award · Stock Appreciation Right | +23,045 | 23,045 |
Page 27 of 52 · 1,021 trades